Zhongchao Inc. Announces Naiditawei® Enrolled as a Listed Online Procurement Drug in Ten Provinces(Districts, Cities) in China

Stock Information for Zhongchao Inc - Ordinary Shares - Class A

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Zhongchao Inc - Ordinary Shares - Class A

Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications
Zhongchao Inc. Announces 1-for-10 Share Consolidation
Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments
Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day
Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients
Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management
Zhongchao Inc. Partners with Ximalaya to Launch the First Audio Course Series for Cancer Education
Zhongchao Inc. Launch Digital Online Education Platform for Common Diseases Clinical Diagnosis and Treatment

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.